InspireMD, Inc. Eliminates CCO Role; Chief Commercial Officer to Depart

What Happened
InspireMD, Inc. (NSPR) filed a Form 8-K reporting an executive change: on July 23, 2026 the company notified Chief Commercial Officer Shane Gleason that his position was eliminated. Mr. Gleason’s final day of employment with the company will be July 31, 2026. The 8-K was filed on July 29, 2026.

Key Details

• Notice of position elimination delivered: July 23, 2026.
• Last day of employment for Shane Gleason: July 31, 2026.
• Role affected: Chief Commercial Officer (CCO).
• The filing includes the company’s interactive cover page data (Inline XBRL) as an exhibit.

Why It Matters
An elimination of the Chief Commercial Officer role is a material executive change because the CCO oversees commercial strategy, sales and market execution—areas that can affect revenue growth and partnership development. The filing does not announce a replacement or provide details on severance or restructuring; investors should monitor subsequent filings and company communications for plans to fill the role or reorganize commercial operations. This 8-K is an executive-change notice, not a financial/earnings report.